These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28374576)

  • 1. Docking-based design and synthesis of galantamine-camphane hybrids as inhibitors of acetylcholinesterase.
    Stavrakov G; Philipova I; Zheleva-Dimitrova D; Valkova I; Salamanova E; Konstantinov S; Doytchinova I
    Chem Biol Drug Des; 2017 Nov; 90(5):709-718. PubMed ID: 28374576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors.
    Stavrakov G; Philipova I; Lukarski A; Atanasova M; Zheleva D; Zhivkova ZD; Ivanov S; Atanasova T; Konstantinov S; Doytchinova I
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32717861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking-based Design of Galantamine Derivatives with Dual-site Binding to Acetylcholinesterase.
    Stavrakov G; Philipova I; Zheleva D; Atanasova M; Konstantinov S; Doytchinova I
    Mol Inform; 2016 Jul; 35(6-7):278-85. PubMed ID: 27492242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity.
    Atanasova M; Stavrakov G; Philipova I; Zheleva D; Yordanov N; Doytchinova I
    Bioorg Med Chem; 2015 Sep; 23(17):5382-9. PubMed ID: 26260334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Novel Acetylcholinesterase Inhibitor by Fragment-Based Design and Virtual Screening.
    Stavrakov G; Philipova I; Lukarski A; Atanasova M; Georgiev B; Atanasova T; Konstantinov S; Doytchinova I
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33916760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
    Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
    Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D
    Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design.
    Greenblatt HM; Guillou C; Guénard D; Argaman A; Botti S; Badet B; Thal C; Silman I; Sussman JL
    J Am Chem Soc; 2004 Dec; 126(47):15405-11. PubMed ID: 15563167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrids of oxoisoaporphine-tacrine congeners: novel acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation inhibitors.
    Tang H; Zhao LZ; Zhao HT; Huang SL; Zhong SM; Qin JK; Chen ZF; Huang ZS; Liang H
    Eur J Med Chem; 2011 Oct; 46(10):4970-9. PubMed ID: 21871694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Bartolini M; Bottegoni G; Bisi A; Cavalli A; Andrisano V; Rampa A
    Eur J Med Chem; 2011 May; 46(5):1682-93. PubMed ID: 21397996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
    Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
    Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition mechanism of fisetin on acetylcholinesterase and its synergistic effect with galantamine.
    Shi W; Han W; Liao Y; Wen J; Zhang G
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jan; 305():123452. PubMed ID: 37769468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
    Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Static Binding and Dynamic Transporting-Based Design of Specific Ring-Chain-Ring Acetylcholinesterase Inhibitor: From Galantamine to Natural Product.
    Zhang Z; Lv J; Wang Y; Yu H; Guo B; Zhai J; Wang C; Zhao Y; Fan F; Luo W
    Chemistry; 2023 May; 29(25):e202203363. PubMed ID: 36826395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors.
    Alpan AS; Parlar S; Carlino L; Tarikogullari AH; Alptüzün V; Güneş HS
    Bioorg Med Chem; 2013 Sep; 21(17):4928-37. PubMed ID: 23891231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
    Camps P; Formosa X; Galdeano C; Muñoz-Torrero D; Ramírez L; Gómez E; Isambert N; Lavilla R; Badia A; Clos MV; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Huertas O; Dafni T; Luque FJ
    J Med Chem; 2009 Sep; 52(17):5365-79. PubMed ID: 19663388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel dual acetylcholinesterase inhibitors with antifibrillogenic activity related to Alzheimer's disease.
    de Almeida JR; Figueiro M; Almeida WP; de Paula da Silva CHT
    Future Med Chem; 2018 May; 10(9):1037-1053. PubMed ID: 29676170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as dual inhibitors for cholinesterases and amyloid beta aggregation.
    Luo W; Li YP; He Y; Huang SL; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
    Bioorg Med Chem; 2011 Jan; 19(2):763-70. PubMed ID: 21211982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.